UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 806

Sortiert nach

PHP150 Searching for a Threshold in Hungary

Value in health, 2012-11, Vol.15 (7), p.A315-A315

Borsi, A

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary

PloS one, 2019-06, Vol.14 (6), p.e0218071-e0218071

2019

Link zum Volltext

Verfügbarkeit prüfen

Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa

BMC neurology, 2024-02, Vol.24 (1), p.61-61

2024

Link zum Volltext

Verfügbarkeit prüfen

Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study

European psychiatry, 2017-09, Vol.45, p.97-103

2017

Link zum Volltext

Verfügbarkeit prüfen

Housing and the City

1st, 2022

Link zum Volltext

Verfügbarkeit prüfen

PRM67 The Use of Health Economic Models in Hungarian Health Technology Assessment

Value in health, 2012-11, Vol.15 (7), p.A472-A472

2012

Link zum Volltext

Verfügbarkeit prüfen

Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in Schizophrenia

Value in health, 2013-11, Vol.16 (7), p.A546-A547

2013

Link zum Volltext

Verfügbarkeit prüfen

EE243 Utilization of Healthcare Resources and Costs of Hemolytic Disease of Fetus and Newborn (HDFN) in Israel

Value in health, 2023-12, Vol.26 (12), p.S97-S98

2023

Link zum Volltext

Verfügbarkeit prüfen

Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)

Frontiers in pharmacology, 2020-04, Vol.11, p.412

2020

Link zum Volltext

Verfügbarkeit prüfen

HSD87 Physician Reported Reasons for Cidp Treatment Choice across 5 European Countries: Results from a Real-World Survey

Value in health, 2023-12, Vol.26 (12), p.S310

2023

Link zum Volltext

Verfügbarkeit prüfen

PGI11 Cost per Responder and Remitter Analysis Comparing Ustekinumab to Comparator Treatments for Moderate-to-Severe Ulcerative Colitis in the United Kingdom

Value in health, 2020-12, Vol.23, p.S535-S535

2020

Link zum Volltext

Verfügbarkeit prüfen

Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study)

Internal and emergency medicine, 2021-04, Vol.16 (3), p.741-748

2021

Link zum Volltext

Verfügbarkeit prüfen

RWD137 Changing Priorities Among Physician Reported Reasons for Choice of Pharmacological gMG Treatments Across 5 European Countries

Value in health, 2022-12, Vol.25 (12), p.S475-S476

2022

Link zum Volltext

Verfügbarkeit prüfen

RWD104 Delayed Diagnosis Amongst gMG Patients: Results From a European Real-World Study

Value in health, 2022-12, Vol.25 (12), p.S468-S469

2022

Link zum Volltext

Verfügbarkeit prüfen

P800 Treatment patterns for biologics in ulcerative colitis and Crohn’s disease: A Danish Nationwide Register Study from 2003 to 2015

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S628-S628

2020

Link zum Volltext

Verfügbarkeit prüfen

DOP78 Intestinal surgery rates in ulcerative colitis and Crohn’s disease in the era of biologics: A Danish Nationwide Register Study from 2003 to 2016

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S116-S117

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of surgery and its complications in ulcerative colitis patients in clinical practice: A systematic literature review of real-world evidence in Europe

International journal of surgery open, 2020, Vol.22, p.22-32

2020

Link zum Volltext

Verfügbarkeit prüfen

P091 Switching to TNFi versus non-TNFi biologics in Crohn’s Disease patients: Real-world outcomes from a German claims data analysis

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S189-S191

2021

Link zum Volltext

Verfügbarkeit prüfen

P793 The cost burden of Crohn’s disease and ulcerative colitis dependent on biologic treatment status – a register-based Danish population study from 2003 to 2015

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S519-S519

2019

Link zum Volltext

Verfügbarkeit prüfen

PMH31 - Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in Schizophrenia

Value in health, 2013-11, Vol.16 (7), p.A546-A547

2013

Link zum Volltext

Verfügbarkeit prüfen

P798 Societal costs attributable to Crohn’s disease and ulcerative colitis within the first 5 years after diagnosis: –a Danish Nationwide Cost-of-Illness Study 2003–2015

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S627-S627

2020

Link zum Volltext

Verfügbarkeit prüfen

DOP26 Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn’s disease

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S066-S066

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 806

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(495)
Mit Volltextzugriff
(706)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(370)
Life Sciences & Biomedicine
(190)
Humans
(181)
Technology
(148)
Engineering
(132)
Engineering, Electrical & Electronic
(114)
Physical Sciences
(95)
Biological And Medical Sciences
(70)
Partial Discharges
(67)
Physics
(67)
Oncology
(65)
Female
(63)
Dielectrics And Electrical Insulation
(62)
Power Transformer Insulation
(61)
Male
(55)
Medical Sciences
(55)
Power Transformers
(49)
Oil Insulation
(46)
Exact Sciences And Technology
(44)
Petroleum
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

PHP150 Searching for a Threshold in Hungary

Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary

Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa

Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study

Housing and the City

PRM67 The Use of Health Economic Models in Hungarian Health Technology Assessment

Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in Schizophrenia

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

EE243 Utilization of Healthcare Resources and Costs of Hemolytic Disease of Fetus and Newborn (HDFN) in Israel

The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections

Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)

HSD87 Physician Reported Reasons for Cidp Treatment Choice across 5 European Countries: Results from a Real-World Survey

PGI11 Cost per Responder and Remitter Analysis Comparing Ustekinumab to Comparator Treatments for Moderate-to-Severe Ulcerative Colitis in the United Kingdom

Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study)

RWD137 Changing Priorities Among Physician Reported Reasons for Choice of Pharmacological gMG Treatments Across 5 European Countries

RWD104 Delayed Diagnosis Amongst gMG Patients: Results From a European Real-World Study

P800 Treatment patterns for biologics in ulcerative colitis and Crohn’s disease: A Danish Nationwide Register Study from 2003 to 2015

DOP78 Intestinal surgery rates in ulcerative colitis and Crohn’s disease in the era of biologics: A Danish Nationwide Register Study from 2003 to 2016

Impact of surgery and its complications in ulcerative colitis patients in clinical practice: A systematic literature review of real-world evidence in Europe

P091 Switching to TNFi versus non-TNFi biologics in Crohn’s Disease patients: Real-world outcomes from a German claims data analysis

P793 The cost burden of Crohn’s disease and ulcerative colitis dependent on biologic treatment status – a register-based Danish population study from 2003 to 2015

PMH31 - Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in Schizophrenia

P798 Societal costs attributable to Crohn’s disease and ulcerative colitis within the first 5 years after diagnosis: –a Danish Nationwide Cost-of-Illness Study 2003–2015

Correction: The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections

DOP26 Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn’s disease

Suchergebnisse filtern